Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1987 Aug 15;246(1):25–36. doi: 10.1042/bj2460025

The identification of epitopic sites in human alpha 1-proteinase inhibitor.

X J Zhu 1, S S Kang 1, K Hargrove 1, D Shochat 1, M Jarrells 1, M Mojesky 1, S K Chan 1
PMCID: PMC1148236  PMID: 2445337

Abstract

Human alpha 1-proteinase inhibitor (alpha 1-PI) yielded nine fragments on cleavage with CNBr. The amino acid sequences of these fragments were determined. Three of these CNBr-cleavage fragments, namely fragment I (residues 64-220), fragment II (residues 243-351) and fragment III (residues 1-63), were found to bind rabbit polyclonal antibodies against chemically oxidized alpha 1-PI and mouse polyclonal antibodies against native alpha 1-PI by the Bio-Dot method (enzyme-linked immunosorbent assay on nitrocellulose). These fragments, I, II and III, inhibited by 60%, 25% and 5% respectively the binding between alpha 1-PI and the rabbit antibodies. Fragments I, II and III were subjected to proteolytic digestion, and 15, ten and five peptides were obtained from these fragments respectively. Only four of these peptides showed binding to the mouse antibodies against native alpha 1-PI. These were residues 40-63, 79-86, 176-206 and 299-323. A panel of monoclonal antibodies was prepared by conventional hybridoma technology, with chemically oxidized alpha 1-PI as the antigen. The ability of the monoclonal antibodies to bind native alpha 1-PI and CNBr-cleavage fragments I-III was determined. The monoclonal antibodies fell into three categories. Most (over 90%) belonged to group I, which was capable of binding alpha 1-PI and only fragment I. Antibodies in groups II and III bound alpha 1-PI and either fragment II or fragment III respectively. The ability of the peptides derived from proteolytic digestion of fragments I, II and III to bind three monoclonal antibodies representing each of the three groups was determined. Among all the peptides tested, only one (residues 176-206) derived from fragment I showed binding to the antibodies from group I, one (residues 299-323) derived from fragment II showed binding to the antibodies from group II, and one (residues 40-63) from fragment III showed binding to the antibodies from group III. Each of these three peptides also inhibited the binding between alpha 1-PI and the corresponding monoclonal antibodies. From these data we concluded that at least four epitopic regions (residues 40-63, 79-86, 176-206 and 299-323) were present in alpha 1-PI. Specific monoclonal antibodies to three of these sites were obtained.

Full text

PDF
25

Images in this article

26Fig. 1.
on p.26
32Fig. 6.
on p.32
33Fig. 8.
on p.33
34Fig. 10.
on p.34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atassi M. Z. Antigenic structure of myoglobin: the complete immunochemical anatomy of a protein and conclusions relating to antigenic structures of proteins. Immunochemistry. 1975 May;12(5):423–438. doi: 10.1016/0019-2791(75)90010-5. [DOI] [PubMed] [Google Scholar]
  2. Atassi M. Z. Antigenic structures of proteins. Their determination has revealed important aspects of immune recognition and generated strategies for synthetic mimicking of protein binding sites. Eur J Biochem. 1984 Nov 15;145(1):1–20. doi: 10.1111/j.1432-1033.1984.tb08516.x. [DOI] [PubMed] [Google Scholar]
  3. Atassi M. Z. Precise determination of the entire antigenic structure of lysozyme: molecular features of protein antigenic structures and potential of "surface-simulation" synthesis--a powerful new concept for protein binding sites. Immunochemistry. 1978 Dec;15(12):909–936. doi: 10.1016/0161-5890(78)90126-8. [DOI] [PubMed] [Google Scholar]
  4. Beach C. M., Chan S. K., Vanaman T. C., Coleman M. S. Terminal deoxynucleotidyltransferase. Alignment of alpha- and beta-subunits of the core enzyme along the primary translation product. Biochem J. 1985 May 1;227(3):1003–1007. doi: 10.1042/bj2271003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Benjamin D. C., Berzofsky J. A., East I. J., Gurd F. R., Hannum C., Leach S. J., Margoliash E., Michael J. G., Miller A., Prager E. M. The antigenic structure of proteins: a reappraisal. Annu Rev Immunol. 1984;2:67–101. doi: 10.1146/annurev.iy.02.040184.000435. [DOI] [PubMed] [Google Scholar]
  6. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  7. Carrell R. W., Jeppsson J. O., Laurell C. B., Brennan S. O., Owen M. C., Vaughan L., Boswell D. R. Structure and variation of human alpha 1-antitrypsin. Nature. 1982 Jul 22;298(5872):329–334. doi: 10.1038/298329a0. [DOI] [PubMed] [Google Scholar]
  8. Engvall E. Enzyme immunoassay ELISA and EMIT. Methods Enzymol. 1980;70(A):419–439. doi: 10.1016/s0076-6879(80)70067-8. [DOI] [PubMed] [Google Scholar]
  9. Hawkes R., Niday E., Gordon J. A dot-immunobinding assay for monoclonal and other antibodies. Anal Biochem. 1982 Jan 1;119(1):142–147. doi: 10.1016/0003-2697(82)90677-7. [DOI] [PubMed] [Google Scholar]
  10. Hodges L. C., Chan S. K. Locations of oligosaccharide chains in human alpha 1-protease inhibitor and oligosaccharide structures at each site. Biochemistry. 1982 May 25;21(11):2805–2810. doi: 10.1021/bi00540a036. [DOI] [PubMed] [Google Scholar]
  11. Hodges L. C., Laine R., Chan S. K. Structure of the oligosaccharide chains in human alpha 1-protease inhibitor. J Biol Chem. 1979 Sep 10;254(17):8208–8212. [PubMed] [Google Scholar]
  12. Hurn B. A., Chantler S. M. Production of reagent antibodies. Methods Enzymol. 1980;70(A):104–142. doi: 10.1016/s0076-6879(80)70044-7. [DOI] [PubMed] [Google Scholar]
  13. Kurachi K., Chandra T., Degen S. J., White T. T., Marchioro T. L., Woo S. L., Davie E. W. Cloning and sequence of cDNA coding for alpha 1-antitrypsin. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6826–6830. doi: 10.1073/pnas.78.11.6826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lando G., Berzofsky J. A., Reichlin M. Antigenic structure of sperm whale myoglobin. I. Partition of specificities between antibodies reactive with peptides and native protein. J Immunol. 1982 Jul;129(1):206–211. [PubMed] [Google Scholar]
  15. Lando G., Reichlin M. Antigenic structure of sperm whale myoglobin. II. Characterization of antibodies preferentially reactive with peptides arising in response to immunization with the native protein. J Immunol. 1982 Jul;129(1):212–216. [PubMed] [Google Scholar]
  16. Mega T., Lujan E., Yoshida A. Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. I. Isolation of glycopeptides. J Biol Chem. 1980 May 10;255(9):4053–4056. [PubMed] [Google Scholar]
  17. Peterson J. D., Nehrlich S., Oyer P. E., Steiner D. F. Determination of the amino acid sequence of the monkey, sheep, and dog proinsulin C-peptides by a semi-micro Edman degradation procedure. J Biol Chem. 1972 Aug 10;247(15):4866–4871. [PubMed] [Google Scholar]
  18. Shochat D., Staples S., Hargrove K., Kozel J. S., Chan S. K. Primary structure of human alpha1-protease inhibitor. The complete amino acid sequence of cyanogen bromide fragment II. J Biol Chem. 1978 Aug 25;253(16):5630–5634. [PubMed] [Google Scholar]
  19. Tarr G. E. A general procedure for the manual sequencing of small quantities of peptides. Anal Biochem. 1975 Feb;63(2):361–370. doi: 10.1016/0003-2697(75)90358-9. [DOI] [PubMed] [Google Scholar]
  20. Vaughan L., Lorier M. A., Carrell R. W. alpha 1-Antitrypsin microheterogeneity. Isolation and physiological significance of isoforms. Biochim Biophys Acta. 1982 Mar 4;701(3):339–345. doi: 10.1016/0167-4838(82)90237-0. [DOI] [PubMed] [Google Scholar]
  21. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  22. Zhu X. J., Chan S. K. The use of monoclonal antibodies to distinguish several chemically modified forms of human alpha 1-proteinase inhibitor. Biochem J. 1987 Aug 15;246(1):19–23. doi: 10.1042/bj2460019. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES